Osteoporosis: Weekly 28.2ug teriparatide reduces vertebral fracture risk
Once-Weekly Injection of Low-Dose Teriparatide (28.2 ug) Reduced the Risk of Vertebral Fracture in Patients with Primary OsteoporosisCalcif Tissue Int. 2014 Feb;94(2):170-5. doi: 10.1007/s00223-013-9777-8. Epub 2013 Aug 21
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
316 primary osteoporosis patients were randomized to receive a 28.2ug injection of teriparatide or placebo injection (1.4ug teriparatide) once-weekly for 3 years, to determine the effects of teriparatide on vertebral fracture prevention and lumbar spine BMD. Results indicated that teriparatide reduced the risk of vertebral fractures and increased lumbar bone mineral density compared to placebo, bu...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue